RetinalGenix Technologies (RTGN) Total Debt (2021 - 2026)
RetinalGenix Technologies (RTGN) reported Total Debt of $49000.0 for Q1 2026, little changed on a YoY basis from $49000.0 in Q1 2025, and down 50.0% sequentially from $98000.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Total Debt (2021 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 6 years of Total Debt data on file, last reported at $49000.0 in Q1 2026.
- For the quarter ending Q1 2026, Total Debt changed 0.0% year-over-year to $49000.0; the trailing twelve-month figure through Mar 2026 stood at $49000.0 (changed 0.0% YoY), and the FY2025 full-year result was $98000.0, up 100.0% from the prior year.
- Total Debt declined to $49000.0 in Q1 2026, from $98000.0 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $98000.0 in Q4 2022 to a low of $48000.0 in Q3 2022.
- A 5-year average of $57529.4 and a median of $49000.0 in 2023 frame the typical range for Total Debt.
- Across the five-year window, Total Debt tumbled 70.77% in 2022 and surged 100.0% in 2025, its largest moves.
- Tracing RTGN's Total Debt over 5 years: stood at $98000.0 in 2022, then tumbled by 50.0% to $49000.0 in 2023, then changed by 0.0% to $49000.0 in 2024, then surged by 100.0% to $98000.0 in 2025, then tumbled by 50.0% to $49000.0 in 2026.
- Business Quant data shows RTGN's Total Debt at $49000.0 in Q1 2026, $98000.0 in Q4 2025, and $49000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.48 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.14 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 49,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49,000.00 |
| Dec 31, 2025 | 98,000.00 |
| Sep 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 49,000.00 |
| Dec 31, 2022 | 98,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Jun 30, 2022 | 73,000.00 |
| Mar 31, 2022 | 73,000.00 |
| Dec 31, 2021 | 73,000.00 |
| Sep 30, 2021 | 164,233.00 |